Phosphotyrosine Profiling of NSCLC Cells in Response to EGF and HGF Reveals Network Specific Mediators of Invasion

Overview

Journal J Proteome Res

Publisher American Chemical Society

Specialty Biochemistry

Date 2013 Feb 27

PMID 23438512

Citations 16

Authors

Hannah Johnson

Rebecca S Lescarbeau

Jesus A Gutierrez

Forest M White

Affiliations

Soon will be listed here.

Abstract

Growth factor signaling is deregulated in cancer and often leads to invasion, yet receptor tyrosine kinase signaling pathways driving invasion under different growth factor conditions are not well understood. To identify specific signaling molecules regulating invasion of A549 non-small cell lung carcinoma (NSCLC) cells downstream of the epidermal growth factor receptor (EGFR) and Met, quantitative site-specific mass spectrometric analysis of tyrosine phosphorylation was performed following epidermal growth factor (EGF) or hepatocyte growth factor (HGF) stimulation, at three different growth factor concentrations and at two time points. Through this analysis, the temporal and concentration dependent phosphorylation profiles were obtained for 131 and 139 sites downstream of EGF and HGF stimulation, respectively. To characterize the effect of these signaling network alterations, we quantified 3D cell migration/invasion through Matrigel. Partial least-squares regression (PLSR) analysis was performed to identify the tyrosine phosphorylation sites most strongly correlated with EGF and/or HGF mediated invasion. Potential common and specific signaling events required for driving invasion downstream of EGFR and Met were identified using either a combined or two independent PLSR models, based on the quantitative EGF or HGF data. Our data highlight the integration and compartmentalization of signaling required for invasion in cancer.

Citing Articles

Phosphorylation of tyrosine 90 in SH3 domain is a new regulatory switch controlling Src kinase.

Koudelkova L, Pelantova M, Bruhova Z, Sztacho M, Pavlik V, Panek D Elife. 2023; 12.

PMID: 37428018 PMC: 10361714. DOI: 10.7554/eLife.82428.

Predictive data-driven modeling of C-terminal tyrosine function in the EGFR signaling network.

Gerritsen J, Faraguna J, Bonavia R, Furnari F, White F Life Sci Alliance. 2023; 6(8).

PMID: 37169593 PMC: 10176108. DOI: 10.26508/lsa.202201466.

A Fresh Look at the Structure, Regulation, and Functions of Fodrin.

Sreeja J, John R, Dharmapal D, Nellikka R, Sengupta S Mol Cell Biol. 2020; 40(17).

PMID: 32601107 PMC: 7431051. DOI: 10.1128/MCB.00133-20.

Phosphorylation Sites in Protein Kinases and Phosphatases Regulated by Formyl Peptide Receptor 2 Signaling.

Annunziata M, Parisi M, Esposito G, Fabbrocini G, Ammendola R, Cattaneo F Int J Mol Sci. 2020; 21(11).

PMID: 32471307 PMC: 7312799. DOI: 10.3390/ijms21113818.

Role of cytokines in combinatorial immunotherapeutics of non-small cell lung cancer through systems perspective.

Misra P, Singh S Cancer Med. 2019; 8(5):1976-1995.

PMID: 30997737 PMC: 6536974. DOI: 10.1002/cam4.2112.

References

Sporn M, Roberts A . Autocrine growth factors and cancer. Nature. 1985; 313(6005):745-7. DOI: 10.1038/313745a0. View

Huang P, Mukasa A, Bonavia R, Flynn R, Brewer Z, Cavenee W . Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci U S A. 2007; 104(31):12867-72. PMC: 1937558. DOI: 10.1073/pnas.0705158104. View

Hiramoto-Yamaki N, Takeuchi S, Ueda S, Harada K, Fujimoto S, Negishi M . Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. J Cell Biol. 2010; 190(3):461-77. PMC: 2922637. DOI: 10.1083/jcb.201005141. View

Bottaro D, Rubin J, Faletto D, Chan A, Kmiecik T, Woude G . Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991; 251(4995):802-4. DOI: 10.1126/science.1846706. View

Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello M . Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2005; 366(1):2-16. DOI: 10.1016/j.gene.2005.10.018. View

Meerschaert K, Bruyneel E, de Wever O, Vanloo B, Boucherie C, Bracke M . The tandem PDZ domains of syntenin promote cell invasion. Exp Cell Res. 2007; 313(9):1790-804. DOI: 10.1016/j.yexcr.2007.03.014. View

Huang P, Miraldi E, Xu A, Kundukulam V, Del Rosario A, Flynn R . Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol Biosyst. 2010; 6(7):1227-37. PMC: 3291333. DOI: 10.1039/c001196g. View

Katz M, Amit I, Citri A, Shay T, Carvalho S, Lavi S . A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration. Nat Cell Biol. 2007; 9(8):961-9. DOI: 10.1038/ncb1622. View

Rong S, Segal S, Anver M, Resau J, Woude G . Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A. 1994; 91(11):4731-5. PMC: 43862. DOI: 10.1073/pnas.91.11.4731. View

10.

Hammond D, Hyde R, Kratchmarova I, Beynon R, Blagoev B, Clague M . Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks. J Proteome Res. 2010; 9(5):2734-42. DOI: 10.1021/pr100145w. View

11.

Zhang Y, Wolf-Yadlin A, Ross P, Pappin D, Rush J, Lauffenburger D . Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol Cell Proteomics. 2005; 4(9):1240-50. DOI: 10.1074/mcp.M500089-MCP200. View

12.

De Larco J, Todaro G . Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A. 1978; 75(8):4001-5. PMC: 392918. DOI: 10.1073/pnas.75.8.4001. View

13.

Mazzocca A, Coppari R, De Franco R, Cho J, Libermann T, Pinzani M . A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 2005; 65(11):4728-38. DOI: 10.1158/0008-5472.CAN-04-4449. View

14.

Lokman N, Ween M, Oehler M, Ricciardelli C . The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 2011; 4(2):199-208. PMC: 3170418. DOI: 10.1007/s12307-011-0064-9. View

15.

Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S . A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 1994; 77(2):261-71. DOI: 10.1016/0092-8674(94)90318-2. View

16.

Weidner K, Di Cesare S, Sachs M, Brinkmann V, Behrens J, Birchmeier W . Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature. 1996; 384(6605):173-6. DOI: 10.1038/384173a0. View

17.

Hynes N, Lane H . ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005; 5(5):341-54. DOI: 10.1038/nrc1609. View

18.

Naldini L, Weidner K, Vigna E, Gaudino G, Bardelli A, Ponzetto C . Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 1991; 10(10):2867-78. PMC: 452997. DOI: 10.1002/j.1460-2075.1991.tb07836.x. View

19.

Fischer O, Giordano S, Comoglio P, Ullrich A . Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J Biol Chem. 2004; 279(28):28970-8. DOI: 10.1074/jbc.M402508200. View

20.

Brinkmann V, Foroutan H, Sachs M, Weidner K, Birchmeier W . Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol. 1995; 131(6 Pt 1):1573-86. PMC: 2120656. DOI: 10.1083/jcb.131.6.1573. View